Home Tools
Log in
Cart

CGRP Receptor

CGRP receptor is found in myelinated A-fibers axon which is required for ligand specificity and function of the receptor. The CGRP receptor has three subunits: receptor activity-modifying protein 1 (RAMP1), calcitonin-like receptor (CLR) and receptor component protein (RCP).[17] The complex central receptor is the G protein-coupled receptor calcitonin receptor-like receptor (CALCRL) which is necessary for CGRP and adrenomedullin (AM receptors). For function CGRP, CALCRL must coincide with RAMP1 where the ligand-binding domain of CGRP is located.
Cat. No. Product name CAS No. Purity Chemical Structure
TP1040 Calcitonin (salmon) 47931-85-1 98%
Calcitonin salmon, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
T6590 MK-3207 Hydrochloride 957116-20-0 98%
MK-3207 is a potent CGRP receptor antagonist with IC50 and Kiof 0.12 nM and 0.022 nM, highly selective versus human AM1, AM2, CTR, and AMY3. Phase 2.
TP1257L Adrenomedullin (AM) (22-52), human acetate 98%
Adrenomedullin (AM) (22-52), human acetate is an antagonist of calcitonin generelated peptide receptor in the hindlimb vascular bed of the cat and an adrenomedul...
T16107 ML230 1776055-05-0 98%
ML230 is a selective ATP-binding cassette (ABC) transporter ABCG2 inhibitor. It 36-fold selective for ABCG2 over ABCB1 (EC50s: 0.13 μM and 4.65 μM, respectively)...
T8682 Vazegepant hydrochloride 1414976-20-7 98%
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
TP2167 β-CGRP, human acetate TP2167 98%
β-CGRP, human acetate is one of calcitonin peptides and acts via the complex of receptor-activity-modifying protein (RAMP) and calcitonin-receptor-like receptor ...
TP1040L Calcitonin(salmon) Acetate(47931-85-1(free base)) TP1040L 98%
Calcitonin(salmon) Acetate, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
T12293L Olcegepant 204697-65-4 98%
Olcegepant is an effective and selective non-peptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (IC50 of 0.03 nM and Ki of 14.4 pM for human C...
T13453 CGRP antagonist 1 1123757-49-2 98%
CGRP antagonist 1 is a potent CGRP receptor antagonist with Ki values of 35 nM and IC50 values of 57 nM, respectively.CGRP antagonist 1 can be used for the study...
T17194 Ubrogepant 1374248-77-7 98%
Ubrogepant is a novel oral calcitonin gene-related peptide receptor antagonist in development for acute treatment of migraine.
TP1134L HCGRP-(8-37) acetate TP1134L 98%
HCGRP-(8-37) acetate is a human calcitonin gene-related peptide (hCGRP) fragment acetate and also an antagonist of CGRP receptor.
T4610 Rimegepant 1289023-67-1 98%
BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
Calcitonin (salmon)
TP1040
Calcitonin salmon, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
MK-3207 Hydrochloride
T6590
MK-3207 is a potent CGRP receptor antagonist with IC50 and Kiof 0.12 nM and 0.022 nM, highly selective versus human AM1, AM2, CTR, and AMY3. Phase 2.
Adrenomedullin (AM) (22-52), human acetate
TP1257L
Adrenomedullin (AM) (22-52), human acetate is an antagonist of calcitonin generelated peptide receptor in the hindlimb vascular bed of the cat and an adrenomedul...
ML230
T16107
ML230 is a selective ATP-binding cassette (ABC) transporter ABCG2 inhibitor. It 36-fold selective for ABCG2 over ABCB1 (EC50s: 0.13 μM and 4.65 μM, respectively)...
Vazegepant hydrochloride
T8682
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
β-CGRP, human acetate
TP2167
β-CGRP, human acetate is one of calcitonin peptides and acts via the complex of receptor-activity-modifying protein (RAMP) and calcitonin-receptor-like receptor ...
Calcitonin(salmon) Acetate(47931-85-1(free base))
TP1040L
Calcitonin(salmon) Acetate, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.
Olcegepant
T12293L
Olcegepant is an effective and selective non-peptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (IC50 of 0.03 nM and Ki of 14.4 pM for human C...
CGRP antagonist 1
T13453
CGRP antagonist 1 is a potent CGRP receptor antagonist with Ki values of 35 nM and IC50 values of 57 nM, respectively.CGRP antagonist 1 can be used for the study...
Ubrogepant
T17194
Ubrogepant is a novel oral calcitonin gene-related peptide receptor antagonist in development for acute treatment of migraine.
HCGRP-(8-37) acetate
TP1134L
HCGRP-(8-37) acetate is a human calcitonin gene-related peptide (hCGRP) fragment acetate and also an antagonist of CGRP receptor.
Rimegepant
T4610
BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.